Celularity Analyst Ratings
Celularity Analyst Ratings
While ratings are subjective and will change, the latest Celularity (CELU) rating was a initiated with a price target of $0.00 to $15.00. The current price Celularity (CELU) is trading at is $2.80, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/25/2022 | 435.71% | Alliance Global Partners | → $15 | Initiates Coverage On | → Buy |
| 08/23/2022 | 114.29% | Truist Securities | $10 → $6 | Maintains | Hold |
| 06/22/2022 | 435.71% | HC Wainwright & Co. | → $15 | Initiates Coverage On | → Buy |
| 04/06/2022 | — | Truist Securities | Downgrades | Buy → Hold | |
| 01/28/2022 | 221.43% | Oppenheimer | → $9 | Initiates Coverage On | → Outperform |
| 11/24/2021 | 221.43% | Morgan Stanley | → $9 | Initiates Coverage On | → Equal-Weight |
| 10/19/2021 | 328.57% | Truist Securities | → $12 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析师事务所 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/25/2022 | 435.71% | 联盟全球合作伙伴 | → 15 美元 | 启动覆盖范围开启 | → 购买 |
| 2022 年 8 月 23 日 | 114.29% | Truist 证券 | 10 美元 → 6 美元 | 维护 | 保持 |
| 06/22/2022 | 435.71% | HC Wainwright & Co. | → 15 美元 | 启动覆盖范围开启 | → 购买 |
| 04/06/2022 | — | Truist 证券 | 降级 | 买入 → 持有 | |
| 01/28/2022 | 221.43% | 奥本海默 | → 9 美元 | 启动覆盖范围开启 | → 跑赢大盘 |
| 11/24/2021 | 221.43% | 摩根士丹利 | → 9 美元 | 启动覆盖范围开启 | → 重量相等 |
| 10/19/2021 | 328.57% | Truist 证券 | → 12 美元 | 启动覆盖范围开启 | → 购买 |
Celularity Questions & Answers
Cellarity 问题与解答
The latest price target for Celularity (NASDAQ: CELU) was reported by Alliance Global Partners on August 25, 2022. The analyst firm set a price target for $15.00 expecting CELU to rise to within 12 months (a possible 435.71% upside). 7 analyst firms have reported ratings in the last year.
联盟全球合作伙伴于2022年8月25日公布了Celularity（纳斯达克股票代码：CELU）的最新目标股价。该分析公司将目标股价设定为15.00美元，预计CELU将在12个月内上涨至15.00美元（可能上涨435.71％）。去年有7家分析公司公布了评级。
The latest analyst rating for Celularity (NASDAQ: CELU) was provided by Alliance Global Partners, and Celularity initiated their buy rating.
Celularity（纳斯达克股票代码：CELU）的最新分析师评级由联盟全球合作伙伴提供，Celularity启动了买入评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Celularity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Celularity was filed on August 25, 2022 so you should expect the next rating to be made available sometime around August 25, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Celularity的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。Celularity的最后一次评级是在2022年8月25日提交的，因此您应该预计下一个评级将在2023年8月25日左右公布。
While ratings are subjective and will change, the latest Celularity (CELU) rating was a initiated with a price target of $0.00 to $15.00. The current price Celularity (CELU) is trading at is $2.80, which is within the analyst's predicted range.
尽管评级是主观的，而且会发生变化，但最新的Celularity（CELU）评级是启动的，目标股价为0.00美元至15.00美元。Celularity（CELU）目前的交易价格为2.80美元，在分析师的预测区间内。
